Broad Institute

Broad Institute, established in 2004, is a leading research institution dedicated to advancing biological understanding and developing novel treatments for human diseases. Leveraging genomics, the institute focuses on identifying new therapeutic approaches. Its primary operations are situated in Cambridge, Massachusetts, contributing significantly to the scientific landscape. The institute's research spans critical areas such as biomedical advancements, genomic studies, and environmental science, producing valuable insights and innovative solutions.

With an employee range of 1,000 to 5,000 individuals, Broad Institute operates at a significant scale, fostering a collaborative environment for scientific discovery. This extensive team supports its mission-driven research, aiming to translate complex biological data into actionable medical strategies. The institute's commitment to its personnel is reflected in its team structure and operational capacity, enabling ambitious research projects. For a closer look at the individuals driving this innovation, one can Meet Broad Institute's team.

Financially, Broad Institute reported a substantial revenue of $831.1M, underscoring its capacity to fund extensive research and development initiatives. This financial strength supports its position among key competitors in the biomedical research sector, including The Jackson Laboratory and Cold Spring Harbor Laboratory. The institute's work is crucial for pushing the boundaries of medical science and developing next-generation therapies. Further details on its financial performance and metrics are available via Explore financial highlights.